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Light-triggered drug release from hydrogels is a promising method to improve efficiency of antitumor
treatment, as an alternative to existing photodynamic therapies. Here we report a photochromic
supramolecular low-MW hydrogel that can quickly and selectively release a physically encapsulated
potent anticancer agent upon green light irradiation under physiological conditions.Numerous advanced drug delivery systems are based on
hydrogels, which can protect labile drugs from premature
degradation, or maintain constant drug concentration in blood
over prolonged periods of time.1 Macroscopic gels can be used
in the form of implants, whereas microgels allow for oral and
pulmonary delivery, and nanogels can be systemically admin-
istered into the bloodstream of patients.2,3 While covalent
hydrogels are based on polymers (gelatin, alginate, agarose),
supramolecular low-MW hydrogels4 can be formed by mutual
non-covalent interactions of short linear oligopeptides,5–10
nucleobases,11 or urea derivatives.12,13 Hydrogels can be trig-
gered by external stimuli, such as pH changes or enzymes, to
release encapsulated drugs in a controllable fashion.14–17 Light
is a particularly attractive stimulus in this context,18 because it
can be applied on living organisms with high spatiotemporal
precision without their permanent contamination. Light-
responsive supramolecular hydrogels,19–23 oen tailored to
particular applications like cargo release,24,25 or shape
memory,26 frequently contain molecular photoswitches –
structures that can reversibly interconvert between two photo-
isomers upon irradiation.27 The associated modulation of
geometry, polarity, or other molecular properties may elicit
macroscopic effects in various materials.28–33
Common photoswitches are usually triggered with UV light,
but this frequency does not penetrate living cells or tissuesr Institut für Technologie, Campus Süd,
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efficiently. Therefore, photoswitches triggered with visible light are
developed for applications in complex biological systems.34–41 In
azobenzenes, such a bathochromic shi is usually associated with
loss of thermal stability. Notable exceptions are ortho-uorinated
azobenzene derivatives, mutually switchable with green (trans /
cis) and violet (cis/ trans) light between two photoisomers, which
are thermally (meta)stable at ambient conditions.42 This motif was
used in numerous light-triggered materials43–45 and biological
applications.46–50
Our group has previously merged the excellent hydrogelation
propensity of amphiphilic cyclic dipeptides51–53 with the pho-
toswitchable azobenzene motif. The resulting biocompatible
photochromic hydrogels can reversibly dissipate to uids upon
irradiation (due to the reversible polarity change ensuing azo-
benzene photoisomerization) under physiological conditions,
and concomitantly release encapsulated bioactive
substances.54,55 However, due to the non-covalent nature of the
encapsulation, substantial spontaneous cargo diffusion (“leak-
ing”) from loaded gels in darkness was oen observed, thus
compromising selectivity of the light-triggered release. More-
over, hydrogels based on the bis-ortho-uoroazobenzene pho-
tochrome (sensitive on green light) only formed above the
critical gelator concentration (CGC) of 40 g L1. Consequently,
complete gel dissipation required relatively long irradiation
time ($3 h).55 The selectivity and timespan were sufficient for
a proof-of-principle demonstration of green-light control over
bacterial growth by photocontrolled antibiotic release.
However, these parameters must be improved before thera-
peutic applications were conceivable for human subjects.
In this communication, we report a successful strategy
towards decreasing the CGC, and increasing selectivity of the
light-induced cargo release in photochromic supramolecular
hydrogels based on cyclic dipeptide gelators.
It is known that aromatic C–F bonds may generate new non-
covalent interactions in proximity of the uorine atoms.56 We
hypothesized that the tetra-ortho-uorinated azobenzene© 2021 The Author(s). Published by the Royal Society of Chemistry
Scheme 1 Schematic depiction (detailed on the Scheme S1†) of
synthesis of the photochromic supramolecular hydrogelator 1 bearing
the “TFAB” photoswitch (framed and abbreviated as R). Upon depro-
tection, the molecule 8 can also yield the TFAB-substituted (S)-alanine
12, which has previously been biosynthetically incorporated into


























































































View Article Online(TFAB) should improve supramolecular association of the bre
subunits and thus decrease the critical gelator concentration in
comparison to the previously demonstrated hydrogelator, based
on the bis-ortho-uorinated azobenzene.55
The hydrogelator 1 (Fig. 1) has been prepared according to
the synthetic route depicted in Schemes 1 and S1.† The crucial
intermediate – bis-uorinated (S)-phenylalanine analogue 5 was
synthesized from 4-bromo-2,6-diuoroaniline (4) and the pro-
tected (R)-iodoalanine (3) using Negishi coupling. Mills reaction of
5 with in situ generated 2,6-diuoronitrosobenzene (6) and
subsequent methyl ester hydrolysis provided the photochromic
amino acid derivative 8 (>96% ee, Fig. S14†), which upon coupling
to an (S)-lysine derivative and cyclization of the linear dipeptide 11
yielded the hydrogelator 1. Additionally, full deprotection of 8may
provide an enantioselective access to the amino acid 12, previously
used as racemate for biosynthetic incorporation into luciferase
protein using the amber codon suppression method.50
Irradiation of 1 in aqueous solution (phosphate-buffered
saline, pH 7.4 – a typical buffer for biological experiments,
abbreviated below as PBS, composed of 8 g NaCl, 0.2 g KH2PO4,
1.15 g Na2HPO4, and 0.2 g KCl in 1 L of water) with green light
(530 nm LED, 7 mW cm2) until equilibration resulted in the
mixture containing 89% of the cis-1. Further exposure of this
solution on violet light (410 nm LED, 9 mW cm2) produced
a mixture containing 23% of the cis-1 (Fig. S1 and Table S1†). In
darkness, the thermal cis / trans isomerization of 1 at r.t. is
practically suppressed. At 60 C, the thermal isomerization of
cis-1 (t1/2 ¼ 70.9  0.6 h at 60  2 C, in MeCN, Fig. S2† le) is
slightly faster than for the unsubstituted cis-TFAB (“F4”, t1/2 ¼
92 h at the same temperature in MeCN42).
Another common limitation for in vivo applications of azo-
benzene derivatives in biological systems is their reduction with
biogenic thiols to arylhydrazines. The compound 1 is resistant
(below 8% of degradation within 6 days of incubation, Fig. S2†
right) to 5.0 mM reduced glutathione solution – an established
model of the intracellular redox environment.Fig. 1 Photochromic cyclic dipeptide trans-1 is a low-MW supramo-
lecular hydrogelator, while its photoisomer cis-1 forms non-viscous
fluids at the same concentrations; a photochromic hydrogel based on
1 (here, 17 g L1 of 1 in PBS, pH 7.4) reversibly dissipates to a fluid upon
irradiation with green light.
© 2021 The Author(s). Published by the Royal Society of ChemistryThe compound 1 forms stable and homogenous hydrogels in
aqueous solutions under physiological conditions (PBS buffer,
pH 7.4, Fig. 1) at the concentrations $15 g L1 of 1 (Table S2†).
Although this value is still over a magnitude higher above the
most efficient UV-light-triggered super(organo)gelators (CGC <
0.1 wt%),21,22 our material enables drug release in water with
visible light – not reported for supergelators yet.
Aer 30 minutes of irradiation with green light (530 nm,
power input of 3 W, 7 mW cm2, 22  2 C), hydrogels con-
taining 15 g L1 or 17 g L1 of 1 turned into homogenous uids
without any mechanical stimulation (Fig. 1 and S4†), while the
hydrogel containing 20 g L1 of 1 needed slight mechanical
stimulation (e.g. by shaking the vial). Gels containing 30 g L1 of
1 or above withstood 60 min of irradiation under the same
conditions without any visible phase transition. All the afore-
mentioned uids remained liquid for the period of at least one
week when stored in darkness at room temperature. The uid
produced upon green-light irradiation of the hydrogel con-
taining 20 g L1 of 1 has been subsequently irradiated with
violet light (410 nm LED, 9 mW cm2) for 60 min and incubated
overnight (16 h) at room temperature in darkness. Aer that
time, the sample turned into a transparent hydrogel again, with
mechanical stability comparable to the non-irradiated sample
(Fig. S5†). The internal brous structure of the hydrogels has
been visualized using transmission electron microscopy (TEM)
(Fig. S6†). We have also investigated gelation of 1 under
a broader range of pH values in aqueous buffers at the constant
concentration of 17 g L1 of 1. At the pH 10, the material did not
dissolve up to the boiling point and no gelation was observed
upon cooling. Samples buffered to the pH 4, pH 6, and pH 8
formed homogenous solutions above c.a. 60 C, and upon short
boiling formed homogenous hydrogels within 1 h of cooling at
room temperature. The hydrogel formed at pH 4 was mechan-
ically unstable and dissipated upon slight shaking or vial
inversion. Hydrogels formed at pH 6 and pH 8 exhibited similar
mechanical and thermal stability as the hydrogel prepared at


























































































View Article OnlineOur next goal on the way to therapeutic relevance of our
drug-releasing hydrogels was to minimize the passive cargo
diffusion (“leaking”) from non-irradiated gel samples, which
previously varied between 5% and 30% of respective light-
induced release rates. We noticed that the “leaking” is less
pronounced for the cargo negatively charged under physiolog-
ical conditions (e.g.DNA oligomers,54 or carboxylic acids55). This
was attributed to electrostatic interactions with the basic,
positively charged lysine side chains, likely exposed on the ber
surface of the gel matrix. This interaction would, in turn, slow
down the diffusion of acidic cargo through cavities of the gel
matrix.
Here we decided to assume a different approach. Fast self-
healing of our gels (<1 min, based on rheological determina-
tion of the storage modulus G0 recovery upon 100% deforma-
tion, Fig. S5†) indicates its highly dynamic nature, where
supramolecular interactions between monomeric units are
quickly reconstituted upon deformation. We hypothesized that
a cargo bearing the cyclic dipeptide motif connected to an
aromatic residue would be promptly incorporated into the
brous structure of the hydrogel (Fig. 2), instead of being
absorbed in the cavities between bers. As photoisomerization
breaks the brous structures, the non-photochromic cargo
would then be released from the supramolecular network upon
hydrogel erosion.
Many clinically approved drugs contain the cyclic dipeptide
motif (2,5-diketopiperazine, DKP) bound to aromatic residues.
They show a broad spectrum of activities – to name only tada-
lal (the active ingredient of “Cialis®” – a drug against erectile
dysfunctions), retosiban (an oxytocin receptor inhibitor used for
the treatment of premature birth), or aplaviroc (a CCR5 entry
inhibitor developed for treatment of HIV infections).57
To test our hypothesis, we have selected a strong anti-
proliferative agent plinabulin (2) (Fig. 2), which is a promising
anticancer drug candidate.58 It acts as a low-nanomolar inhib-
itor of tubulin depolymerization, which hampers cytoskeleton
dynamics. The resulting mitotic arrest stops cell division andFig. 2 Schematic representation of supramolecular interactions
between the gelator 1 and a potent anticancer agent plinabulin (2).
Hydrogen bonding and hydrophobic interactions of aromatic rings,
most likely stabilize drugmolecules inside of the fibrous network of the
hydrogel and prevent its leaking in darkness.
8548 | RSC Adv., 2021, 11, 8546–8551the cancer growth.59 2 shares structural similarities, in partic-
ular the cyclic dipeptide residue and an aromatic substituent,
with the gelator 1. We have synthesized 2 following a literature
procedure (Scheme S2†).60
Aerwards we encapsulated 2 in the hydrogel composed of
17 g L1 of 1 in PBS pH 7.4, and characterized its release upon
dissipation of the gel resulting from green light irradiation. To
our delight, the cargo could be recovered almost quantitatively
in solution upon light-driven gel dissipation within 30 min,
while “leaking” from identical gels incubated in darkness was
negligible (below 1%, Fig. 3). For comparison, an antibiotic
ciprooxacin (with similar MW and a structure unrelated to the
gelator 1) encapsulated and released upon light-induced dissi-
pation of the otherwise identical gel composition showed over
25% leaking in darkness within the same time period (Fig. S7†).
Due to limited solubility of plinabulin (2) in water, stock
solutions of 2 were prepared in DMSO and diluted 100-fold in
aqueous solutions for the nal formulations. We determined
the aqueous solubility of 2 (PBS pH 7.4, 1% DMSO) in absence
of the gelator 1 to be 7.5 1.7 mmol L1 (2.5 mg L1). Above this
concentration, visible precipitation appeared within 60 minutes
from diluting the DMSO stock solutions with PBS (for the
original drug, the issue of low water solubility was addressed
e.g. by covalent functionalization with hydrophilic PEG groups).
However, hydrogels (17 g L1 of 1) comprising the compound
2 at nal concentrations #350 mmol L1 (118 mg L1) (by
adding respectively more concentrated DMSO stock solutions
during the preparation process) were still transparent and
without any precipitation upon prolonged time (>16 h). This
additionally supports the hypothesis that 2 is being incorpo-
rated into the supramolecular structure of the hydrogel upon its
formation. The dopant 2 still constitutes below 1% of the dry
mass of the gelator 1 used in the respective composition,Fig. 3 Light-induced release of encapsulated plinabulin 2 (56 mg)
upon dissipation of the hydrogel (0.5 mL) containing 17 g L1 of 1
caused by irradiation with green light (530 nm LED, 7 mW cm2) (green
circles). Passive diffusion (“leaking”) of 2 from the same hydrogel in
darkness (black squares) is negligible. Suppression of the “leaking” is
attributed to the supramolecular association of 2 and trans-1 in fibres.


























































































View Article Onlinetherefore no signicant alterations of the gel physical properties
(melting temperature, or mechanical strength) have been
observed.
An important factor in potential therapeutic applications of
the demonstrated drug-releasing material is the toxicity of the
drug delivery vehicle to human cells. This was determined for
our gelator 1 using cell viability assays (MTT assays). We have
treated one human cancerous (HeLa) and one non-cancerous
(NHDF – broblasts) cell line with increasing concentrations
of the gelator 1 as pure trans-isomer (the thermally stable form
that forms hydrogels in water), or as a mixture obtained upon
irradiation of trans-1 with green light until the respective pho-
tostationary state was achieved (this mixture corresponds to the
dissipated hydrogel). In all but one combination (Fig. S9†) we
observed no signicant decrease in cell viability up to the
concentrations of 1 mM of 1 (c.a. 0.45 g L1, slightly below the
CGC values). Only in the case when cancerous HeLa cells were
exposed to the pure trans-1, the cell viability strongly decreased
above the concentration of 0.1 mM of the gelator 1.
To further assess applicability of our composition for ther-
apeutic purposes, we considered that the irradiation power
required for the gel dissipation in our experiments (<10 mW
cm2) is considerably lower than the safety limits determined
for human tissues (200 mW cm2).24 In contrast to photody-
namic therapies (PDT) used clinically to treat malignant
cancers,61 tissues targeted with our gel composition would not
need to be oxygenated. Furthermore, the clinically existing PDT
infrastructure could be used for the release of 2 upon photo-
degradaton of our hydrogel.
In the future, the efficiency of our system will have to be
conrmed in vivo (e.g. in model mice with tumor xenogras),
before human therapeutic applications can be considered.
Particularly suitable therapeutic targets for the currently pre-
sented composition seem to be retina cancers or squamous
carcinoma (skin cancer), which appear in organs that can be
efficiently penetrated with green light.
The composition demonstrated here could be further
formulated as micro/nanogel (with eventual stabilization, e.g.
by covering with biocompatible alginate), and injected into the
bloodstream, or given upon inhalation. With the reported low-
nanomolar antitumor potency of plinabulin 2 (IC50 ¼ 15 nM
against human colon cancer HT-29 cells60), systemic introduc-
tion of such a microformulated hydrogel containing 0.35 mM of
2, followed by its rapid and close-to-quantitative light-driven
discharge in the selected area, should produce sufficiently
high local drug concentration to successfully eradicate neigh-
boring tumor cells. At the same time, the remaining drug will
circulate in darkness in its inactive form (entrapped in the gel
bers), eventually metabolized and cleared from the organism
over a prolonged period of time, thus minimizing the systemic
toxicity and resulting in better therapeutic effect in comparison
to neat plinabulin.
The remaining challenge is modication of the photo-
chromic segment of our system to cause the gel dissipation
upon irradiation with red or near-IR frequencies (within the so-
called “therapeutic window” of light, 650–900 nm), capable of
deep penetration (>1 cm) of so human tissues. This would© 2021 The Author(s). Published by the Royal Society of Chemistryenable e.g. a general strategy for targeting of solid tumors inside
of human organs without surgical intervention with established
and efficient cytotoxic agents, yet withminimizing systemic side
effects. Therefore, in the future we will examine the applicability
of ortho-alkoxy and ortho-chlorinated azobenzenes, which were
efficiently switched upon red light irradiation,39,40 in our
hydrogel systems.
Conclusions
In conclusion, we demonstrated that the gelator 1, non-toxic for
non-cancerous human cells below 1 mM concentrations, forms
stable supramolecular hydrogels at and above concentrations of
15 g L1 under physiological conditions and in the pH range 6–
8. The gels can be reversibly dissipated to uids with green
light, and concomitantly release previously encapsulated cargo.
Moreover, we identied a potent anticancer agent plinabulin 2
as an optimal therapeutic agent, which due to the structural
similarity with 1 can be encapsulated and quickly released from
the dissipating hydrogel upon irradiation, while its diffusion
(“leaking”) outside of the intact gel in darkness is negligible.
The concentration of 2 in our supramolecular composition can
be over 40-fold higher than its aqueous solutions, without dis-
turbing the gel homogeneity. This additionally enhances
delivery efficiency of 2 in therapeutic use.
Formulation of such compositions as injectable or inhalable
micro/nanogels may enable systemic introduction into organ-
isms. Subsequent cargo release with laser or LED green irradi-
ation will produce a high local concentration of the cytotoxic
agent. The local dose can be much higher than the concentra-
tion achieved upon simple drug injection, without causing
severe side effects outside of the irradiation area, and thus
enable faster and more efficient cancer eradication. Due to the
penetration propensity of green light, eye and skin cancers
remain the primary targets for this composition. In contrary to
photodynamic therapies, the targeted tissues do not have to be
oxygenated.
Extension of the described methodology to the red- or NIR-
light-induced gel dissipation is also foreseen to enable target-
ing of solid human tumours on the organismal scale. The
release of other drugs based on the cyclic dipeptide (DKP) motif
will be also investigated.
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